The Pandemic Will End: How and Why
In many ways we’ve been fortunate. Despite a pandemic, society has not broken down.
dcw
Alzheimer’s Patient Newsletter February 2020
Aducanumab, the first Alzheimer’s-modifying therapy, submitted to the FDA. Can Biogen recover from their errors?
MS Patient Newsletter December 2019
The field of MS research has had amazing success in the last two decades.
Alzheimer’s Patient Newsletter July 2019
One day, one of the trials in Alzheimer’s disease will be positive. We think this trial may already be underway.